[Neonatal meningitis, ventriculitis, intraventricular therapy or not?]. 1985

E Schretlen, and H Muytjens, and J Slooff

Neonatal meningitis still remains a disease with high mortality in spite of systemic treatment with in vitro active antibiotics. Of 42 consecutive cases, the fatality rate was 36%; Among the 27 survivors, there were 7 patients with extensive neurological and psychological impairment. The pathogenesis of the ventriculitis is discussed on the basis of the histomorphological structure of the ependyma, the subependymal tissue and the glycogen-rich choroid plexus within the first few weeks after birth. It seems, that this structure facilitates local bacterial growth and acts as a bacterial reservoir, relatively resistant to antimicrobial agents. The goal of therapy in neonatal meningitis should be directed to achieve a high concentration of the antimicrobial agent in the fore mentioned tissues. The intraventricular route should be considered.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D004660 Encephalitis Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition. Inflammation, Brain,Rasmussen Syndrome,Brain Inflammation,Encephalitis, Rasmussen,Rasmussen Encephalitis,Rasmussen's Syndrome,Brain Inflammations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

E Schretlen, and H Muytjens, and J Slooff
November 1978, Journal of the National Medical Association,
E Schretlen, and H Muytjens, and J Slooff
April 2024, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,
E Schretlen, and H Muytjens, and J Slooff
March 2016, Acta neurochirurgica,
E Schretlen, and H Muytjens, and J Slooff
June 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
E Schretlen, and H Muytjens, and J Slooff
December 1977, The Journal of pediatrics,
E Schretlen, and H Muytjens, and J Slooff
May 1973, Journal of neurosurgery,
E Schretlen, and H Muytjens, and J Slooff
January 2017, Surgical neurology international,
E Schretlen, and H Muytjens, and J Slooff
January 1979, Journal of neurosurgery,
Copied contents to your clipboard!